Survivorship: from research to reality

Article

The 6th Biennial Cancer Survivorship Research Conference: has a great tag after the colon, "Translating Science to Cancer."For the last five meeting, attendees have heard the results of research with lots of statistics and numbers about what should be done. But this year, the focus is on how to implement programs that will bring about the changes the survivor community has been asking for. For example, you read about the research Barbara Anderson, PhD, completed at The Ohio State University in our article All Stressed Out. Anderson's research showed psychological interventions to reduce stress improved survival for the breast cancer patients being studied. The results, published in the journal Cancer in 2008, reported the results of a long-term trial of 227 breast cancer patients who were randomized to either participate in psychological interventions to manage stress after breast cancer treatment or to only be assessed and receive no interventions. The intervention consisted of small-group sessions conducted by psychologists who taught participants strategies to reduce stress and improve quality of life. Specific strategies included progressive muscle relaxation (a series of exercises in which participants tense and release specific muscle groups for stress reduction), problem-solving for common difficulties such as fatigue, identifying supportive family members or friends who were capable of providing assistance, using assertive communication to get their psychological and medical needs met, strategies to increase daily activity such as walking, improving dietary habits, and finding ways to cope with treatment side effects and maintaining adherence to medical treatment and follow-up. While results such as these would be front page news if it was a pill, Anderson's study received little coverage. She has stayed with her research and will begin training clinicians in how to deliver the interventions this year. In other sessions during the next three days we'll be looking at where we are in side effects and late effects in a number of areas. I'll keep you posted.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content